Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.

Andersson F, Cline C, Rydén-Bergsten T, Erhardt L.

Pharmacoeconomics. 1999 Jun;15(6):535-50. Review.

PMID:
10538327
2.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
3.

Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.

Colquitt JL, Mendes D, Clegg AJ, Harris P, Cooper K, Picot J, Bryant J.

Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560. Review.

4.

A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.

McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S.

Health Technol Assess. 2010 May;14(24):1-162. doi: 10.3310/hta14240. Review.

5.

Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.

Szucs TD.

Am J Hypertens. 1997 Oct;10(10 Pt 2):272S-279S. Review.

PMID:
9366284
6.
7.

The pharmacoeconomics of ACE inhibitors in chronic heart failure.

McMurray J, Davie A.

Pharmacoeconomics. 1996 Mar;9(3):188-97. Review.

PMID:
10160096
8.

Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond.

Lombardi WL, Litwin SE.

Coron Artery Dis. 1999 Sep;10(6):361-8. Review.

PMID:
10474785
9.
10.

Angiotensin receptor blockers for heart failure.

Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003040. doi: 10.1002/14651858.CD003040.pub2. Review.

PMID:
22513909
11.

Underutilisation of ACE inhibitors in patients with congestive heart failure.

Bungard TJ, McAlister FA, Johnson JA, Tsuyuki RT.

Drugs. 2001;61(14):2021-33. Review.

PMID:
11735631
12.

Moderately Elevated Blood Pressure: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Sep.

13.

Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials.

Gheorghiade M, Benatar D, Konstam MA, Stoukides CA, Bonow RO.

Am J Cardiol. 1997 Oct 30;80(8B):14H-27H. Review. Erratum in: Am J Cardiol 1998 Jun 15;81(12):1521.

PMID:
9372994
14.

Beta-blockers and heart failure.

Cruickshank JM.

Indian Heart J. 2010 Mar-Apr;62(2):101-10. Review.

PMID:
21180298
16.

Therapies to prevent heart failure post-myocardial infarction.

Thomas KL, Velazquez EJ.

Curr Heart Fail Rep. 2005 Dec;2(4):174-82. Review.

PMID:
16332310
17.
18.

Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversies.

Huckell VF, Bernstein V, Crowell R, Dagenais GR, Higginson LA, Isserow S, Laramée P, Liu P, McCans JL, Orchard RC, Prewitt R, Quinn BP, Samson M, Turazza F, Warnica JW, Wielgosz A.

Can J Cardiol. 1997 Feb;13(2):173-82. Review.

PMID:
9070169
19.

Moderately Elevated Blood Pressure: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2004 Oct.

20.

What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?

Reynolds G, Hall AS, Ball SG.

Eur J Clin Pharmacol. 1996;49 Suppl 1:S35-9. Review.

PMID:
8834930

Supplemental Content

Support Center